CAPN6 in disease: An emerging therapeutic target (Review)
- Authors:
- Lin Chen
- Dongqiong Xiao
- Fajuan Tang
- Hu Gao
- Xihong Li
-
Affiliations: Department of Emergency Medicine, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China - Published online on: September 21, 2020 https://doi.org/10.3892/ijmm.2020.4734
- Pages: 1644-1652
-
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Sorimachi H, Hata S and Ono Y: Calpain chronicle-an enzyme family under multidisciplinary characterization. Proc Jpn Acad Ser B Phys Biol Sci. 87:287–327. 2011. View Article : Google Scholar : | |
Moretti D, Del Bello B, Allavena G and Maellaro E: Calpains and cancer: Friends or enemies? Arch Biochem Biophys. 564:26–36. 2014. View Article : Google Scholar : PubMed/NCBI | |
Dear N, Matena K, Vingron M and Boehm T: A new subfamily of vertebrate calpains lacking a calmodulin-like domain: Implications for calpain regulation and evolution. Genomics. 45:175–184. 1997. View Article : Google Scholar : PubMed/NCBI | |
Sorimachi H, Hata S and Ono Y: Impact of genetic insights into calpain biology. J Biochem. 150:23–37. 2011. View Article : Google Scholar : PubMed/NCBI | |
Matena K, Boehm T and Dear N: Genomic organization of mouse Capn5 and Capn6 genes confirms that they are a distinct calpain subfamily. Genomics. 48:117–120. 1998. View Article : Google Scholar : PubMed/NCBI | |
Dear TN and Boehm T: Diverse mRNA expression patterns of the mouse calpain genes Capn5, Capn6 and Capn11 during development. Mech Dev. 89:201–209. 1999. View Article : Google Scholar : PubMed/NCBI | |
Tonami K, Kurihara Y, Aburatani H, Uchijima Y, Asano T and Kurihara H: Calpain 6 is involved in microtubule stabilization and cytoskeletal organization. Mol Cell Biol. 27:2548–2561. 2007. View Article : Google Scholar : PubMed/NCBI | |
Hanna RA, Campbell RL and Davies PL: Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin. Nature. 456:409–412. 2008. View Article : Google Scholar : PubMed/NCBI | |
Glading A, Lauffenburger DA and Wells A: Cutting to the chase: Calpain proteases in cell motility. Trends Cell Biol. 12:46–54. 2002. View Article : Google Scholar : PubMed/NCBI | |
Suzuki K and Sorimachi H: A novel aspect of calpain activation. FEBS Lett. 433:1–4. 1998. View Article : Google Scholar : PubMed/NCBI | |
Campbell RL and Davies PL: Structure-function relationships in calpains. Biochem J. 447:335–351. 2012. View Article : Google Scholar : PubMed/NCBI | |
Liu Y, Mei C, Sun L, Li X, Liu M, Wang L, Li Z, Yin P, Zhao C, Shi Y, et al: The PI3K-Akt pathway regulates calpain 6 expression, proliferation, and apoptosis. Cell Signal. 23:827–836. 2011. View Article : Google Scholar : PubMed/NCBI | |
Barnes TM and Hodgkin J: The tra-3 sex determination gene of Caenorhabditis elegans encodes a member of the calpain regulatory protease family. EMBO J. 15:4477–4484. 1996. View Article : Google Scholar : PubMed/NCBI | |
Goll DE, Thompson VF, Li H, Wei W and Cong J: The calpain system. Physiol Rev. 83:731–801. 2003. View Article : Google Scholar : PubMed/NCBI | |
Mugita N, Kimura Y, Ogawa M, Saya H and Nakao M: Identification of a novel, tissue-specific calpain htra-3; a human homologue of the Caenorhabditis elegans sex determination gene. Biochem Biophys Res Commun. 239:845–850. 1997. View Article : Google Scholar : PubMed/NCBI | |
Hosseini M, Najmabadi H and Kahrizi K: Calpains: Diverse functions but enigmatic. Arch Iran Med. 21:170–179. 2018.PubMed/NCBI | |
Lebart MC and Benyamin Y: Calpain involvement in the remodeling of cytoskeletal anchorage complexes. FEBS J. 273:3415–3426. 2006. View Article : Google Scholar : PubMed/NCBI | |
Sato K and Kawashima S: Calpain function in the modulation of signal transduction molecules. Biol Chem. 382:743–751. 2001. View Article : Google Scholar : PubMed/NCBI | |
Hong JM, Teitelbaum SL, Kim TH, Ross FP, Kim SY and Kim HJ: Calpain-6, a target molecule of glucocorticoids, regulates osteoclastic bone resorption via cytoskeletal organization and microtubule acetylation. J Bone Miner Res. 26:657–665. 2011. View Article : Google Scholar | |
Tonami K, Kurihara Y, Arima S, Nishiyama K, Uchijima Y, Asano T, Sorimachi H and Kurihara H: Calpain-6, a microtubule-stabilizing protein, regulates Rac1 activity and cell motility through interaction with GEF-H1. J Cell Sci. 124:1214–1223. 2011. View Article : Google Scholar : PubMed/NCBI | |
Tonami K, Hata S, Ojima K, Ono Y, Kurihara Y, Amano T, Sato T, Kawamura Y, Kurihara H and Sorimachi H: Calpain-6 deficiency promotes skeletal muscle development and regeneration. PLoS Genet. 9:e10036682013. View Article : Google Scholar : PubMed/NCBI | |
Margiotta A, Progida C, Bakke O and Bucci C: Rab7a regulates cell migration through Rac1 and vimentin. Biochim Biophys Acta Mol Cell Res. 1864:367–381. 2017. View Article : Google Scholar | |
Rodriguez OC, Schaefer AW, Mandato CA, Forscher P, Bement WM and Waterman-Storer CM: Conserved microtubule-actin interactions in cell movement and morphogenesis. Nat Cell Biol. 5:599–609. 2003. View Article : Google Scholar : PubMed/NCBI | |
Mogessie B, Roth D, Rahil Z and Straube A: A novel isoform of MAP4 organises the paraxial microtubule array required for muscle cell differentiation. Elife. 4:e056972015. View Article : Google Scholar : PubMed/NCBI | |
Bryan BA, Li D, Wu X and Liu M: The Rho family of small GTPases: Crucial regulators of skeletal myogenesis. Cell Mol Life Sci. 62:1547–1555. 2005. View Article : Google Scholar : PubMed/NCBI | |
Skubitz KM and Skubitz AP: Differential gene expression in uterine leiomyoma. J Lab Clin Med. 141:297–308. 2003. View Article : Google Scholar : PubMed/NCBI | |
Marion A, Dieudonné FX, Patiño-Garcia A, Lecanda F, Marie PJ and Modrowski D: Calpain-6 is an endothelin-1 signaling dependent protective factor in chemoresistant osteosarcoma. Int J Cancer. 130:2514–2525. 2012. View Article : Google Scholar | |
Liu Y, Wang Y, Sun X, Mei C, Wang L, Li Z and Zha X: miR-449a promotes liver cancer cell apoptosis by downregulation of Calpain 6 and POU2F1. Oncotarget. 7:13491–13501. 2016. View Article : Google Scholar : | |
Su X, Xiao D, Huang L, Li S, Ying J, Tong Y, Ye Q, Mu D and Qu Y: MicroRNA alteration in developing rat oligodendrocyte precursor cells induced by hypoxia-ischemia. J Neuropathol Exp Neurol. 78:900–909. 2019. View Article : Google Scholar : PubMed/NCBI | |
Mahaman YAR, Huang F, Kessete Afewerky H, Maibouge TMS, Ghose B and Wang X: Involvement of calpain in the neuropatho-genesis of Alzheimer's disease. Med Res Rev. 39:608–630. 2019. View Article : Google Scholar | |
Peng P, Wu W, Zhao J, Song S, Wang X, Jia D, Shao M, Zhang M, Li L, Wang L, et al: Decreased expression of Calpain-9 predicts unfavorable prognosis in patients with gastric cancer. Sci Rep. 6:296042016. View Article : Google Scholar : PubMed/NCBI | |
Fichna JP, Macias A, Piechota M, Korostyński M, Potulska- Chromik A, Redowicz MJ and Zekanowski C: Whole-exome sequencing identifies novel pathogenic mutations and putative phenotype-influencing variants in Polish limb-girdle muscular dystrophy patients. Hum Genomics. 12:342018. View Article : Google Scholar : PubMed/NCBI | |
Stumvoll M, Goldstein BJ and van Haeften TW: Type 2 diabetes: Principles of pathogenesis and therapy. Lancet. 365:1333–1346. 2005. View Article : Google Scholar : PubMed/NCBI | |
Miyazaki T, Taketomi Y, Takimoto M, Lei XF, Arita S, Kim-Kaneyama JR, Arata S, Ohata H, Ota H, Murakami M and Miyazaki A: m-Calpain induction in vascular endothelial cells on human and mouse atheromas and its roles in VE-cadherin disorganization and atherosclerosis. Circulation. 124:2522–2532. 2011. View Article : Google Scholar : PubMed/NCBI | |
Matsushita Y, Shimada Y, Kawara S, Takehara K and Sato S: Autoantibodies directed against the protease inhibitor calpastatin in psoriasis. Clin Exp Immunol. 139:355–362. 2005. View Article : Google Scholar : PubMed/NCBI | |
Ono Y, Saido TC and Sorimachi H: Calpain research for drug discovery: Challenges and potential. Nat Rev Drug Discov. 15:854–876. 2016. View Article : Google Scholar : PubMed/NCBI | |
Drag M and Salvesen GS: Emerging principles in protease-based drug discovery. Nat Rev Drug Discov. 9:690–701. 2010. View Article : Google Scholar : PubMed/NCBI | |
Nikkel AL, Martino B, Markosyan S, Brederson JD, Medeiros R, Moeller A and Bitner RS: The novel calpain inhibitor A-705253 prevents stress-induced tau hyperphosphorylation in vitro and in vivo. Neuropharmacology. 63:606–612. 2012. View Article : Google Scholar : PubMed/NCBI | |
Ono Y, Ojima K, Shinkai-Ouchi F, Hata S and Sorimachi H: An eccentric calpain, CAPN3/p94/calpain-3. Biochimie. 122:169–187. 2016. View Article : Google Scholar | |
Skubitz KM and Skubitz AP: Differential gene expression in leiomyosarcoma. Cancer. 98:1029–1038. 2003. View Article : Google Scholar : PubMed/NCBI | |
Marion A, Dieudonné F, Patiño-García A, Lecanda F, Marie P and Modrowski D: Identification of calpain-6 as a new target involved in cell death of bone cancer cells. Bone. 44:S2472009. View Article : Google Scholar | |
Xiang Y, Li F, Wang L, Zheng A, Zuo J, Li M, Wang Y, Xu Y, Chen C, Chen S, et al: Decreased calpain 6 expression is associated with tumorigenesis and poor prognosis in HNSCC. Oncol Lett. 13:2237–2243. 2017. View Article : Google Scholar : PubMed/NCBI | |
Filali H, Vidal E, Bolea R, Márquez M, Marco P, Vargas A, Pumarola M, Martin-Burriel I and Badiola JJ: Gene and protein patterns of potential prion-related markers in the central nervous system of clinical and preclinical infected sheep. Vet Res. 44:142013. View Article : Google Scholar : PubMed/NCBI | |
Markmann A, Schäfer S, Linz W, Löhn M, Busch AE and Wohlfart P: Down-regulation of calpain 9 is linked to hypertensive heart and kidney disease. Cell Physiol Biochem. 15:109–116. 2005. View Article : Google Scholar : PubMed/NCBI | |
Guttula SV, Rao AA, Sridhar GR, Chakravarthy MS, Nageshwararo K and Rao PV: Cluster analysis and phylogenetic relationship in biomarker identification of type 2 diabetes and nephropathy. Int J Diabetes Dev Ctries. 30:52–56. 2010. View Article : Google Scholar : PubMed/NCBI | |
Miyazaki T, Tonami K, Hata S, Aiuchi T, Ohnishi K, Lei XF, Kim-Kaneyama JR, Takeya M, Itabe H, Sorimachi H, et al: Calpain-6 confers atherogenicity to macrophages by dysregulating pre-mRNA splicing. J Clin Invest. 126:3417–3432. 2016. View Article : Google Scholar : PubMed/NCBI | |
Yin SJ, Lee JR, Kwak H, Lee BN, Han JW, Hahn MJ, Park YD and Yang JM: Functional study of 143-3 protein epsilon (YWHAE) in keratinocytes: Microarray integrating bioinformatics approaches. J Biomol Struct Dyn. 38:2633–2649. 2020. View Article : Google Scholar | |
Xia L, Liu Y, Fu Y, Dongye S and Wang D: Integrated analysis reveals candidate mRNA and their potential roles in uterine leiomyomas. J Obstet Gynaecol Res. 43:149–156. 2017. View Article : Google Scholar | |
Zhu L, Sun Y, Wu Q, Zhang C and Ling J: CAPN6 regulates uterine leiomyoma cell proliferation and apoptosis through the Rac1-dependent signaling pathway. Ann Clin Lab Sci. 50:24–30. 2020.PubMed/NCBI | |
Lee SJ, Choi YL, Lee EJ, Kim BG, Bae DS, Ahn GH and Lee JH: Increased expression of calpain 6 in uterine sarcomas and carci-nosarcomas: An immunohistochemical analysis. Int J Gynecol Cancer. 17:248–253. 2007. View Article : Google Scholar : PubMed/NCBI | |
Rho SB, Byun HJ, Park SY and Chun T: Calpain 6 supports tumorigenesis by inhibiting apoptosis and facilitating angiogenesis. Cancer Lett. 271:306–313. 2008. View Article : Google Scholar : PubMed/NCBI | |
Lee SJ, Kim BG, Choi YL and Lee JW: Increased expression of calpain 6 during the progression of uterine cervical neoplasia: Immunohistochemical analysis. Oncol Rep. 19:859–863. 2008.PubMed/NCBI | |
LoRusso PM: Inhibition of the PI3K/AKT/mTOR pathway in solid tumors. J Clin Oncol. 34:3803–3815. 2016. View Article : Google Scholar : PubMed/NCBI | |
Wu XX and Kakehi Y: Enhancement of lexatumumab-induced apoptosis in human solid cancer cells by Cisplatin in caspase-dependent manner. Clin Cancer Res. 15:2039–2047. 2009. View Article : Google Scholar : PubMed/NCBI | |
Grgic I, Eichler I, Heinau P, Si H, Brakemeier S, Hoyer J and Köhler R: Selective blockade of the intermediate-conductance Ca2+-activated K+ channel suppresses proliferation of micro-vascular and macrovascular endothelial cells and angiogenesis in vivo. Arterioscler Thromb Vasc Biol. 25:704–709. 2005. View Article : Google Scholar : PubMed/NCBI | |
Tomatis C, Fiorio Pla A and Munaron L: Cytosolic calcium microdomains by arachidonic acid and nitric oxide in endothelial cells. Cell Calcium. 41:261–269. 2007. View Article : Google Scholar | |
Apte RS, Chen DS and Ferrara N: VEGF in signaling and disease: Beyond discovery and development. Cell. 176:1248–1264. 2019. View Article : Google Scholar : PubMed/NCBI | |
Li J, Meng X, Hu J, Zhang Y, Dang Y, Wei L and Shi M: Heparanase promotes radiation resistance of cervical cancer by upregulating hypoxia inducible factor 1. Am J Cancer Res. 7:234–244. 2017.PubMed/NCBI | |
Oh M, Rho SB, Son C, Park K and Song SY: Non-proteolytic calpain-6 interacts with VEGFA and promotes angiogenesis by increasing VEGF secretion. Sci Rep. 9:157712019. View Article : Google Scholar : PubMed/NCBI | |
Marion A, Dieudonné FX, Marie PJ and Modrowski D: Endothelin-1 up regulates the survival factor calpain-6 in osteo-sarcoma cells through Mapk and PI3K pathways. Bone. 47:S1122010. View Article : Google Scholar | |
Marion A, Dieudonné FX, Patiño-Garcia A, Lecanda F, Marie PJ and Modrowski D: Abnormal expression of calpain-6 due to endothelin-1/NFκB signalling contributes to cell survival and chemoresistance in osteosarcoma cells. Bone. 48:S382011. View Article : Google Scholar | |
Jin W, Wu L, Liang K, Liu B, Lu Y and Fan Z: Roles of the PI-3K and MEK pathways in Ras-mediated chemoresistance in breast cancer cells. Br J Cancer. 89:185–191. 2003. View Article : Google Scholar : PubMed/NCBI | |
Geismann C, Schäfer H, Gundlach JP, Hauser C, Egberts JH, Schneider G and Arlt A: NF-κB dependent chemokine signaling in pancreatic cancer. Cancers (Basel). 11:14452019. View Article : Google Scholar | |
Andrique C, Morardet L, Linares LK, Cissé MY, Merle C, Chibon F, Provot S, Haÿ E, Ea HK, Cohen-Solal M and Modrowski D: Calpain-6 controls the fate of sarcoma stem cells by promoting autophagy and preventing senescence. JCI insight. 3:e1212252018. View Article : Google Scholar : | |
Orosco A, Fromigué O, Bazille C, Entz-Werle N, Levillain P, Marie PJ and Modrowski D: Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma. Cancer Res. 67:3708–3715. 2007. View Article : Google Scholar : PubMed/NCBI | |
Dieudonné FX, Marion A, Marie PJ and Modrowski D: Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice. J Bone Miner Res. 27:2118–2129. 2012. View Article : Google Scholar : PubMed/NCBI | |
Zhao Y, Liao Q, Zhu Y and Long H: Endothelin-1 promotes osteosarcoma cell invasion and survival against cisplatin-induced apoptosis. Clin Orthop Relat Res. 469:3190–3199. 2011. View Article : Google Scholar : PubMed/NCBI | |
Kaci I, Mansouri R, Marie P and Modrowski D: Hypoxia upregulates calpain-6expression in osteosarcoma cells: Implication in cancer stem cells. J Bone Min Res. 28:2013. | |
Bouanga JT, Yoon J and Modrowski D: Contribution of cancer stem cells to the metastatic capacities of osteosarcoma. Calcif Tissue Int. 104:S852019. | |
Zha X: The PI3K-Akt pathway regulates calpain 6 expression, proliferation, and apoptosis. FASEB J. 25:2011. | |
Singh NK: microRNAs databases: Developmental methodologies, structural and functional annotations. Interdiscip Sci. 9:357–377. 2017. View Article : Google Scholar | |
Wong CM, Tsang FH and Ng IO: Non-coding RNAs in hepatocellular carcinoma: Molecular functions and pathological implications. Nat Rev Gastroenterol Hepatol. 15:137–151. 2018. View Article : Google Scholar : PubMed/NCBI | |
Raimbourg Q, Perez J, Vandermeersch S, Prignon A, Hanouna G, Haymann JP, Baud L and Letavernier E: The calpain/calpastatin system has opposing roles in growth and metastatic dissemination of melanoma. PLoS One. 8:e604692013. View Article : Google Scholar : PubMed/NCBI | |
Birch D, Britt BC, Dukes SC, Kessler JA and Dizon ML: MicroRNAs participate in the murine oligodendroglial response to perinatal hypoxia-ischemia. Pediatr Res. 76:334–340. 2014. View Article : Google Scholar : PubMed/NCBI | |
Guo Y, Gong HS, Zhang J, Xie WL, Tian C, Chen C, Shi Q, Wang SB, Xu Y, Zhang BY and Dong XP: Remarkable reduction of MAP2 in the brains of scrapie-infected rodents and human prion disease possibly correlated with the increase of calpain. PLoS One. 7:e301632012. View Article : Google Scholar : PubMed/NCBI | |
Yadavalli R, Guttmann RP, Seward T, Centers AP, Williamson RA and Telling GC: Calpain-dependent endoproteolytic cleavage of PrPSc modulates scrapie prion propagation. J Biol Chem. 279:21948–21956. 2004. View Article : Google Scholar : PubMed/NCBI | |
Donkor I: An update on the therapeutic potential of calpain inhibitors: A patent review. Expert Opin Ther Pat. 1–17. 2020. View Article : Google Scholar : PubMed/NCBI | |
Miyazaki T and Miyazaki A: Dysregulation of calpain proteolytic systems underlies degenerative vascular disorders. J Atheroscler Thromb. 25:1–15. 2018. View Article : Google Scholar : | |
Miyazaki T and Miyazaki A: Emerging roles of calpain proteolytic systems in macrophage cholesterol handling. Cell Mol Life Sci. 74:3011–3021. 2017. View Article : Google Scholar : PubMed/NCBI | |
Miyazaki T and Miyazaki A: Impact of dysfunctional protein catabolism on macrophage cholesterol handling. Curr Med Chem. 26:1631–1643. 2019. View Article : Google Scholar | |
Kang MY, Zhang Y, Matkovich SJ, Diwan A, Chishti AH and Dorn GW II: Receptor-independent cardiac protein kinase Calpha activation by calpain-mediated truncation of regulatory domains. Circ Res. 107:903–912. 2010. View Article : Google Scholar : PubMed/NCBI | |
Taneike M, Mizote I, Morita T, Watanabe T, Hikoso S, Yamaguchi O, Takeda T, Oka T, Tamai T, Oyabu J, et al: Calpain protects the heart from hemodynamic stress. J Biol Chem. 286:32170–32177. 2011. View Article : Google Scholar : PubMed/NCBI | |
Galvez AS, Diwan A, Odley AM, Hahn HS, Osinska H, Melendez JG, Robbins J, Lynch RA, Marreez Y and Dorn GW II: Cardiomyocyte degeneration with calpain deficiency reveals a critical role in protein homeostasis. Circ Res. 100:1071–1078. 2007. View Article : Google Scholar : PubMed/NCBI | |
Moyen C, Goudenege S, Poussard S, Sassi A, Brustis J and Cottin P: Involvement of micro-calpain (CAPN 1) in muscle cell differentiation. Int J Biochem Cell Biol. 36:728–743. 2004. View Article : Google Scholar : PubMed/NCBI | |
Sáenz A, Azpitarte M, Armañanzas R, Leturcq F, Alzualde A, Inza I, García-Bragado F, De la Herran G, Corcuera J, Cabello A, et al: Gene expression profiling in limb-girdle muscular dystrophy 2A. PLoS One. 3:e37502008. View Article : Google Scholar : PubMed/NCBI | |
Hollinger K and Selsby J: The physiological response of protease inhibition in dystrophic muscle. Acta Physiol (Oxf). 208:234–244. 2013. View Article : Google Scholar | |
Raaby L, Otkjær K, Salvskov-Iversen ML, Johansen C and Iversen L: Characterization of the expression of 143-3 isoforms in psoriasis, basal cell carcinoma, atopic dermatitis and contact dermatitis. Dermatol Rep. 2:e142010. View Article : Google Scholar |